You don't need to be signed in to read BMJ Group Blogs, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Most read articles in May

12 Jun, 12 | by BMJ Group

The most read article in May was Kripke and colleagues’ analysis of the association between hypnotics and mortality. Woz et al‘s analysis of post-discharge hospital utilisation, originally published in April, was the second most popular and the newly published paper by Wiberg et al on the relationship between cognitive performance and post-stroke mortality was the third most read.

Click on the titles to read the articles in full.

Rank Author(s) Title
1 Kripke et al Hypnotics’ association with mortality or cancer: a matched cohort study
2 Woz et al Gender as risk factor for 30 days post-discharge hospital utilisation: a secondary data analysis
3 Wiberg et al

The relationship between executive dysfunction and post-stroke mortality: a population-based cohort study

4 Townsend and Pitchford Baby knows best? The impact of weaning style on food preferences and body mass index in early childhood in a case–controlled sample
5 Belghiti et al Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case–control study
6 Nichols et al

What is the optimal level of population alcohol consumption for chronic disease prevention in England? Modelling the impact of changes in average consumption levels

7 Lee et al UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database
8 Gidman et al

Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study

9 Jara et al

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD

10 Hoddinott et al A serial qualitative interview study of infant feeding experiences: idealism meets realism

 

By submitting your comment you agree to adhere to these terms and conditions
You can follow any responses to this entry through the RSS 2.0 feed.